Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new press release headline about the Merck collaboration and INTerpath-001 trial dated August 19, 2026 to the News page. The header now displays updated stock price and trading volume, and an older organizational-change item was removed.
    Difference
    1%
    Check dated 2026-08-22T21:42:13.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The header stock information was updated to reflect different price and volume values for Moderna's stock, altering how the market data is presented on the page.
    Difference
    0.4%
    Check dated 2026-08-15T20:25:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Two new stock metrics ($59.17 and 6.82M) and two new press releases (FDA approval for the influenza vaccine mFLUSIVA and initiation of Phase 1 trial of mRNA-1469) were added. Older stock data ($54.82 and 7.76M) and a prior press release were removed.
    Difference
    5%
    Check dated 2026-08-08T18:28:20.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added the July 31, 2026 press release Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates and updated the stock quote to $54.82 with 7.76M volume. Removed the June 1, 2026 ASCO-related entry for Intismeran Autogene in combination with KEYTRUDA.
    Difference
    1%
    Check dated 2026-08-01T14:20:41.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The header's stock data updated from $61.82 with 4.55M volume to $54.07 with 4.43M volume. This reflects the current market data shown on Moderna's press releases page.
    Difference
    0.5%
    Check dated 2026-07-25T11:42:15.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Stock data in the header updated to $61.82 and 4.55M; a new press release entry titled 'Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors' dated July 16, 2026 was added, and the June 1, 2026 release 'Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus' was removed.
    Difference
    1%
    Check dated 2026-07-18T09:24:47.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.